American Lung Association's $22 Million Commitment to Research
American Lung Association's Commitment to Lung Health
Organization funds 139 projects, continuing its leadership in lung health research
Today, the American Lung Association announced an impressive research investment of $22 million over the past year, marking it as one of the most substantial lung health programs nationwide. With the funding of 139 research grants, including the esteemed Airways Clinical Research Centers (ACRC), the Lung Association is forming essential partnerships aimed at discovering ways to identify, treat, and potentially cure various lung diseases.
"The newly funded projects, which cover a spectrum from asthma and COPD research to lung cancer and respiratory viruses, are integral to the Lung Association's mission of saving lives through improved lung health. Over the last century, the Lung Association has been at the forefront of significant health advancements, including combatting tuberculosis and enhancing treatments for lung cancer, as well as research on respiratory viruses like COVID-19," stated Harold Wimmer, President and CEO of the American Lung Association. "We take pride in escalating our research investment to $22 million to aid in identifying, treating, and ultimately curing the lung diseases that affect millions across the nation."
Wimmer added, "Our research investments are driven by the belief that everyone deserves access to clean and healthy air. By addressing issues related to lung cancer and investigating the health impacts of indoor air, these grants signify a broad commitment to improving lung health and developing solutions for those most affected by lung diseases."
Research Categories and Awards
This year, the awards were allocated across various categories that target vital aspects of lung diseases. The awards included the American Lung Association/AAAAI Allergic Respiratory Diseases Award, American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award, Catalyst Award, among others. These research projects receive funding after undergoing a thorough scientific peer review process, ensuring a wide range of complex issues are addressed effectively.
Three recent notable grantees include:
Public Policy and Public Health Award
James Krings, MD, Washington University of St. Louis School of Medicine. Dr. Krings' study, titled "Dissemination of a cost-analysis of guideline-recommended Single Maintenance and Reliever Therapy (SMART) for asthma," aims to raise Medicaid payor awareness about a unified asthma inhaler treatment known as SMART. This approach combines a long-term anti-inflammatory medicine with a quick-relief medicine, thereby reducing the risk of asthma flare-ups by approximately 30% in comparison to using two separate inhalers. The goal is to enhance outcomes for asthma patients through more accessible and efficient treatment options.
Emerging Respiratory Pathogen Award
Sergejs Berdnikovs, PhD, Northwestern University Feinberg School of Medicine. Dr. Berdnikovs' research titled "Airway metabolic dysfunction and severe respiratory viral infections" investigates the relationship between metabolic diseases and viral infections. With individuals suffering from diabetes and obesity at a considerably higher risk for severe viral infections, including significant complications from COVID-19, the insights gained could help devise prevention strategies or treatments tailored for these vulnerable populations.
Lung Cancer Discovery Award
Milica Momcilovic, MD, PhD, University of California, Los Angeles. Dr. Momcilovic's research, "Estrogen-GPCR signaling axis drives resistance to targeted therapy," is examining how an experimental drug, TAK228, influences tumor growth in lung squamous cell carcinoma (LUSC), a subtype of Non-Small Cell Lung Cancer, especially in conjunction with other therapies. This study holds particular significance for women, as earlier research indicates a connection between estrogen and this form of lung cancer.
The Role of the Lung Association's Research Institute
The Lung Association’s Research Institute encompasses not only the Awards and Grants program but also the Airways Clinical Research Network, the largest not-for-profit clinical research network dedicated to asthma and COPD treatment research. Currently, the Lung Association is accepting applications for the 2025-2026 research awards and grants cycle. Those interested in active research funding opportunities can visit the Lung Association's website for more details.
For further insights about the new grant awardees and the dedicated team at the American Lung Association Research Institute, additional information can be found on their online platform.
About the American Lung Association
The American Lung Association is at the forefront of efforts aimed at saving lives through improved lung health and the prevention of lung diseases. Their mission is centered on four strategic priorities: to eradicate lung cancer; advocate for clean air access for all; enhance life quality for individuals with lung disease and their families; and to foster a tobacco-free future. With a distinguished 4-star rating from Charity Navigator, the organization continues to champion lung health through advocacy, education, and research. For more information about the American Lung Association, individuals can call 1-800-LUNGUSA (1-800-586-4872) or visit their official site.
Frequently Asked Questions
What is the primary focus of the American Lung Association's recent funding?
The primary focus is to enhance lung health research, particularly related to conditions like asthma, COPD, and lung cancer.
How many projects have been funded by the Lung Association?
The American Lung Association has funded 139 research projects with their recent $22 million investment.
Why is this research investment significant?
This investment is crucial as it supports innovative projects aimed at understanding and curing various lung diseases affecting millions.
What awards were given by the American Lung Association?
Awards were given in several categories, including those for public health policy and respiratory pathogen research.
How can individuals get involved with the American Lung Association?
Individuals can participate by attending local events or supporting through donations, helping advance lung health initiatives.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- DZS Transitions WiFi Management to AXON Networks in Major Deal
- Fluid Sensors Market Expected to Reach $27.65 Billion Growth
- 23andMe's Recent Reverse Stock Split: Impact and Insights
- Arq, Inc. to Discuss Q3 2024 Results in Upcoming Call
- ISC Plans to Announce 2024 Q3 Financial Performance Soon
- Tonix Pharmaceuticals Pushes Forward with Fibromyalgia Drug Approval
- Shift to Online Shopping Trends: Insights from 1WorldSync Report
- Understanding 5.6 Million Vacant Homes and Housing Trends in America
- Prosperity Asset Management Welcomes New Leaders to Drive Growth
- Crombie REIT Announces Monthly Distribution for Investors
Recent Articles
- Piper Sandler Initiates Disney Coverage with Neutral Rating
- Citi Analysts Boost Cisco Systems' Rating Amid AI Growth
- Recent Predictions from Ark Invest on Bitcoin's Market Shift
- UPM Redefines 2024 Forecast Amid Market Challenges
- Mazzucato Highlights Innovation Risks at TCI Conference
- Explore Innovations in Cell and Gene Therapies: GenScript Forum
- RBC Capital Markets Upgrades Incitec Pivot to Outperform
- Tenable Holdings Receives Strong Analyst Support Amid Growth Prospects
- Jefferies' Hold Rating on Qualys: A Balanced Growth Perspective
- UK Inflation Decline Fuels Rate Cut Expectations for Reeves
- Tecan Group Faces Setbacks: A Dive into Current Challenges
- Airbus Announces Major Job Reductions in Defence Sector
- Ryanair's Traffic Forecast Adjustment Amid Delivery Delays
- Bill Ackman's Bet on Alphabet: Insights for Investors
- Exploring Game-Changing AI Stocks for Future Growth
- Volatility Hits Trump Media as Shares Experience Major Drop
- ASML Faces Market Concerns Amid Guidance Revisions
- Industrial Transmission Substation Market Expected Growth Surge
- Understanding the Daily NAVs of WisdomTree ETFs
- Medigene AG Showcases Innovations at Key Upcoming Events
- Morgan Stanley's Investment Strategy Shifts Towards Bitcoin ETFs
- Celebrating 110 Years of EICMA: A Legacy in Two-Wheel Innovation
- EICMA 2024: Celebrating 110 Years of Two-Wheeled Innovation
- Airtel and Vonage Unveil Advanced Communications App for Businesses
- Save the Storks and Options for Her Engage Students at Princeton
- Piper Sandler Gives Cautious Neutral Rating to Disney Stock
- Boeing's Capital Raise: A Strategic Move for Future Stability
- Stellantis Issues Recall for Hybrid SUVs Over Brake Safety Issue
- Top Stocks to Consider for Exceptional Growth This Season
- Nvidia's Rapid Growth: A Look at What Lies Ahead
- Kepler Chosen by ESA to Head Innovative Laser Network Project
- Trina Storage Advances Renewable Energy Through UK Project
- Canada and ESA Team Up for Groundbreaking Space Innovations
- Canton Fair Showcases Innovations and Global Trade Opportunities
- Youth Connect Through Art: Bridging Cultures and Ideas
- Japanese Prime Minister Pledges Increased Spending Amid Debt Concerns
- Namibia Central Bank Lowers Interest Rate to Stimulate Growth
- Whitbread Shows Resilience with Strong Growth Plans Despite Shortfalls
- Man Group PLC Discloses Shareholder Positions in Centamin
- Stock Insights: DJT and PHUN See Significant Movements
- AI Hardware Reactions: Insights from Gene Munster on ASML Impact
- Ammonia Market Growth Expected to Reach $91.95 Billion by 2029
- Exyte Strengthens Market Position Through Kinetics Acquisition
- Trina Storage Completes Major Energy Storage Project in the UK
- Gogoro Expands Battery Swapping Service with New Smartscooters
- Market Movements: ASML's Caution and Musk's Financial Boost
- CEO of Goldman Sachs in Saudi Arabia Announces Upcoming Resignation
- ASML's Guidance Cut Sparks Concerns Among Chip Investors
- Stellantis Faces Shipment Challenges Amid Market Shifts
- Exploring the Growth of the VR Headsets Market to 2032